Blindness! [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2015-08-17 17:02 (3969 d 14:48 ago) – Posting: # 15284
Views: 6,370

Dear Detlew,

❝ IMHO "... replicate designs e.g. for substances with highly variable pharmacokinetic characteristics ..." doesn't mean only for that example. And if even the Spanish agreed - why to worry? Paranoia after all the bizarrness or curiosities known from regulatory bodies like this last one?


Oh, I overlooked these two little letters. THX for making it clear to me.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
244 visitors (0 registered, 244 guests [including 29 identified bots]).
Forum time: 07:50 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5